Last reviewed · How we verify
NCT04784572: evadoulim
Assessment of Pain During Intramuscular Injection Delay in Adult Psychiatry
NA trial testing first injection delay and second injection delay in Delayed Antipsychotic Treatment, Pharmacological Factors and Individual Factors in 393 participants. Status unknown.
30 September 2024
Quick facts
| Lead sponsor | Centre hospitalier de Ville-Evrard, France |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | other |
| Enrollment | 393 |
| Start date | 22 January 2021 |
| Primary completion | 30 September 2024 |
| Estimated completion | 31 December 2024 |
| Sites | 1 location across France |
Drugs / interventions tested
- first injection delay and second injection delay
Conditions studied
- Delayed Antipsychotic Treatment, Pharmacological Factors and Individual Factors — all drugs for Delayed Antipsychotic Treatment, Pharmacological Factors and Individual Factors →
Sponsor
Centre hospitalier de Ville-Evrard, France
Who can join
18 and older, any sex, with Delayed Antipsychotic Treatment, Pharmacological Factors and Individual Factors. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Since psychiatry is still too often confronted with a dichotomy between psyche and soma, the assessment of pain and anxiety at RMI is still rarely done (Willer et al., 1982). The objective of this exploratory study is to evaluate the influence of pharmacological factors (type of injected molecules, injection frequency, injection site, treatment duration, treatment dose, time since last injection) and individual about the pain perceived when injecting antipsychotic therapy (diagnosis, sex, age, weight, duration of illness, level of anxiety, psychiatric and somatic comorbidity, insight). In the future, this study will develop a suitable procedure to limit pain and anxiety during RMI. Taking these dimensions into account will probably allow a better compliance of patients for this type of care, and thus a decrease in the number of relapses in the long term.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04784572
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Centre hospitalier de Ville-Evrard, France trials
Trials by the same sponsor.
- NCT07316803 — Group Intervention for Romantic Relationships in Young Adults With Severe Mental Illness · NA · recruiting
- NCT07354633 — Full Sail Ahead, Sailing in Psychosocial Rehabilitation. · NA · recruiting
- NCT06867783 — EVALUATION FOR YOUNG CHILDREN WITH AUTISM SPECTRUM DISORDERS · NA · active not recruiting
- NCT05784961 — Impact of tDCS on Cannabis Craving in Schizophrenia · NA · not yet recruiting
- NCT06263933 — Effect of Experience Sharing and Mutual Assistance on Insight and Recovery During the First Psychotic Episode · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04784572 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Centre hospitalier de Ville-Evrard, France
- Last refreshed: 6 March 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04784572.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing